Annual report for Cadila Healthcare Ltd. for FY-2015
15-05-2015
Zydus to present New Clinical Data on Lipaglyn at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress in Nashville, TN, USA
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated May 12, 2015 titled "Zydus to present New Clinical Data on Lipaglyn at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress in Nashville, TN, USA".12-05-2015
FY15 results on May 15, 2015
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 15, 2015, inter alia, to consider 1. To approve the audited stand-alone and consolidated financial results for the quarter / year ended on March 31, 2015 and 2. To recommend the dividend on equity shares of the Company for the financial year ended on March 31, 2015....27-04-2015
Zydus Group to donate USD 240,000 to The National Institutes of Health, USA for advancing leishmaniasis research
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated April 23, 2015 titled "Zydus Group to donate USD 240,000 to The National Institutes of Health, USA for advancing leishmaniasis research"23-04-2015
Cadila Healthcare seeks nod to raise 10,000 cr from markets
Sends ballot notice to have enabling approvals in place to meet funding needs13-04-2015
Notice of Postal Ballot
Cadila Healthcare Ltd has informed BSE that the members of the Company will consider to approve the resolutions, by way of Postal Ballot.13-04-2015
Company news
The board of directors of Cadila Healthcare on Wednesday decided to obtain enabling approval from shareholders through postal ballot to raise up to 10,000 crore. The funds will be raised t...08-04-2015
Outcome of Board Meeting
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 08, 2015, has been decided to obtain enabling approval of the shareholders' of the Company through postal ballot process for issuance of the following securities.1. Equity Shares including Convertible Bonds/Debenture through Qualified Institutional Placement (QIP) and/or Depository Receipts or any other modes for an amount not exceeding Rs 10,000 Crores; and...08-04-2015
Shareholding Pattern For March 31, 2015
Cadila Healthcare Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.08-04-2015
Updates
Cadila Healthcare Ltd has informed BSE that the Company has purchased 50% shares of Zydus BSV Pharma Private Limited (Zydus BSV) from Bharat Serums and Vaccines Limited and now Zydus BSV has become 100% subsidiary of Cadila Healthcare Limited.26-03-2015